Tri Locum Partners »

Arcturus Therapeutics Hldg I shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5M 111k 31.53
2023-09-30 $5.3M 209k 25.55
2020-12-31 $1.2M 27k 43.37

More positions owned by Tri Locum Partners

Abbvie (ABBV)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Kenvue Put Option (KVUE)
Regeneron Pharmaceuticals (REGN)
Ge Healthcare Technologies I Common Stock (GEHC)
Ascendis Pharma A/s Sponsored Adr (ASND)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Biogen Idec (BIIB)
Catalent (CTLT)
Axsome Therapeutics (AXSM)
Xenon Pharmaceuticals (XENE)
Argenx Se Sponsored Adr (ARGX)
Natera (NTRA)
Legend Biotech Corp Sponsored Ads (LEGN)
Madrigal Pharmaceuticals (MDGL)

View all positions for Tri Locum Partners

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Dimensional Fund Advisors
Goldman Sachs Group
Schonfeld Strategic Advisors
Jupiter Asset Management
Jpmorgan Chase & Co
Wintrust Financial Corporation
Charles Schwab Investment Management
AQR Capital Management
Caption Management
Portolan Capital Management

View all funds holding Arcturus Therapeutics Hldg I